Regulon

Regulon: R-793

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
172.2091111Pr-155Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7005 ENSG00000007866 TEAD3 Q99594
5606 ENSG00000034152 MAP2K3 J3QL77
11284 ENSG00000039650 PNKP Q96T60
5566 ENSG00000072062 PRKACA P17612
9455 ENSG00000103942 HOMER2 Q9NSB8
6560 ENSG00000124067 SLC12A4 Q9UP95
6385 ENSG00000124145 SDC4 P31431
9322 ENSG00000125733 TRIP10 W4VSQ9
6238 ENSG00000125844 RRBP1 Q9P2E9
3949 ENSG00000130164 LDLR P01130
3911 ENSG00000130702 LAMA5 O15230
5045 ENSG00000140564 FURIN P09958
1969 ENSG00000142627 EPHA2 P29317
1717 ENSG00000172893 DHCR7 B4E1K5
9986 ENSG00000173653 RCE1 Q9Y256
23612 ENSG00000174307 PHLDA3 Q9Y5J5
2050 ENSG00000196411 EPHB4 P54760

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
VANDETANIBEPHA2Small moleculeINHIBITORTyrosine-protein kinase SRC inhibitor42
TESEVATINIBERBB2Small moleculeINHIBITOREphrin type-B receptor 4 inhibitor32
JI-101PDGFRBSmall moleculeINHIBITOREphrin type-B receptor 4 inhibitor20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-793

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-12306GPR98down-regulatesZFXactivatesR-793238Drugs (8)